For the year ending 2025-12-31, SBFMW made $36,305,891 in revenue. -$5,210,702 in net income. Net profit margin of -14.35%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 36,305,891 | |||
| Cost of sales | 24,050,214 | |||
| Gross profit | 12,255,677 | |||
| Accounting | 698,083 | |||
| Consulting | 1,571,692 | |||
| Director fees | 400,000 | |||
| Intangible assets impairment | 1,748,247 | |||
| Legal | 385,142 | |||
| Marketing | 1,143,929 | |||
| Office | 3,864,584 | |||
| R&d | 604,308 | |||
| Salaries | 7,265,346 | |||
| Taxes | 469,305 | |||
| Depreciation & amortization | 332,070 | |||
| Total general & administrative expenses | 18,482,706 | |||
| (loss) from operations | -6,227,029 | |||
| Foreign exchange gain (loss) | 2,642 | |||
| Interest income | 280,901 | |||
| Interest expense | 0 | |||
| Gain (loss) on asset sale | -10,257 | |||
| Total other income (expense) | 273,286 | |||
| Net (loss) before income taxes | -5,953,743 | |||
| Provision for income taxes | 21,609 | |||
| Net (loss) | -5,975,352 | |||
| Gain (loss) from foreign exchange translation | 764,650 | |||
| Comprehensive (loss) | -5,210,702 | |||
| Basic EPS | -1.44 | |||
| Basic Average Shares | 4,157,086 | |||
Sunshine Biopharma Inc. (SBFMW)
Sunshine Biopharma Inc. (SBFMW)